Caricamento...
Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?
OBJECTIVES: Evaluation of changes in symptoms among patients with overactive bladder syndrome treated with transdermal oxybutynin and tolerability after 12 months of follow-up. METHODS: This was a multicenter, retrospective, single-cohort, observational study. Changes in symptoms were evaluated prim...
Salvato in:
| Pubblicato in: | Adv Urol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6087608/ https://ncbi.nlm.nih.gov/pubmed/30151004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6782736 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|